Hormone therapy and venous thromboembolism risk in women of menopausal age: a target trial emulation
{{output}}
Contemporary data from randomized clinical trials focusing on the effect of oral hormone therapy (HT) on venous thromboembolism (VTE) in women aged 50-60 years are scarce despite evolving HT regimens. Here, we evaluated the association between HT and the risk ... ...
